Portfolio company
Asher Biotherapeutics
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This biotechnology company develops targeted immunotherapies for patients with cancer, infectious diseases and autoimmune conditions.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Asher Bio
The company develops cis-targeted immunotherapies that selectively activate specific immune cells to treat patients with cancer and other diseases.
Radiant Biotherapeutics
This company develops multi-specific antibody therapies to treat patients with cancer and infectious diseases.
Ankyra Therapeutics
This biotechnology company develops anchored immunotherapy treatments for patients with cancer and other serious immune-mediated diseases.
Reverb Therapeutics
This biotechnology company develops bispecific antibody therapies that redirect the body's natural cytokines to treat patients with cancer and autoimmune diseases.
Artiva Biotherapeutics
The company develops allogeneic natural killer cell therapies for patients with autoimmune diseases and cancer.
HI-Bio
This biotechnology company develops targeted therapies for patients suffering from severe immune-mediated diseases.
Arcellx
This biotechnology company develops cell therapies to treat patients with cancer and autoimmune diseases.
Immunocore
This biotechnology company develops T cell receptor immunotherapies to treat patients with cancer, infectious diseases and autoimmune conditions.
